Sell-Side Guidance for Clinical Research Sites
Managing a clinical research site requires precise operations and dedicated teams advancing medical science. When considering a transition, you need a partner who understands these uncommon challenges and can preserve the integrity of your ongoing studies. Our experienced M&A team at Agenda Health connects you with healthcare buyers who value your research capabilities and support your site’s future growth.
Meeting the Demands of Clinical Research
Clinical research sites are becoming increasingly central to the clinical development process, with nearly 70% of trials now outsourced as sponsors seek greater efficiency, specialization, and flexibility. The sector is evolving quickly, being driven by demand for decentralized trial models, therapeutic expertise, and technology-enabled execution, making it a focal point for both strategic and financial buyers. Our team understands the operational, regulatory, and growth dynamics that clinical research sites face and works closely with founders to evaluate strategic options, from capital raises to potential exits. For well-positioned operators, market conditions suggest it’s an opportune time to plan for what’s next.
Guiding Clinical Innovation & Breakthroughs
With decades worth of healthcare M&A expertise, we help clinical research site owners secure their legacies and sell their practices. Our team understands both the scientific and business aspects of your operation, linking you with buyers who share your affinity for advancing medical knowledge. From maintaining study protocols to preserving staff relationships, we guide you through the sale process with transparency and integrity, affirming your efforts to succeed under new ownership.